Algorithm for Detection and Screening of Familial Hypercholesterolemia in Lithuanian Population

Author:

Aliosaitiene Urte1,Petrulioniene Zaneta1,Rinkuniene Egidija1,Mainelis Antanas2,Brazdziuniene Egle3,Smailyte Urte1,Sileikiene Vaida1,Laucevicius Aleksandras1

Affiliation:

1. Vilnius university, faculty of medicine

2. Vilnius university, faculty of mathematics and informatics

3. Vilnius university hospital Santaros klinikos

Abstract

Abstract BACKGROUND Familial hypercholesterolemia (FH) is one of the most common autosomal dominant diseases. FH causes a lifelong increase in low-density lipoprotein cholesterol (LDL-C) levels, which in turn leads to atherosclerotic cardiovascular disease. FH incidence is widely underestimated and undertreated, despite the availability and effectiveness of lipid-lowering therapy. Patients with FH have an increased cardiovascular risk; therefore, early diagnosis and treatment are vital. To address the burden of FH, several countries have implemented national FH screening programmes. The currently used method for FH detection in Lithuania is mainly opportunistic screening with subsequent cascade screening of index cases’ first-degree relatives.METHODS A total of 428 patients were included in this study. Patients with suspected FH are referred to a lipidology center for thorough evaluation. Patients who met the criteria for probable or definite FH according to Dutch Lipid Clinic Network (DLCN) score system and/or had LDL-C > = 6.5 mmol/l were subjected to genetic testing. Laboratory and instrumental tests, vascular marker data of early atherosclerosis, and consultations by other specialists, such as radiologists and ophthalmologists, were also recorded.RESULTS 127 (30%) patients were genetically tested. FH-related mutations were found in 38.6% (n = 49) of the patients. Coronary artery disease (CAD) was diagnosed in 13% (n = 57) of the included patients, whereas premature CAD was found in 47 (11%) patients. CAD was diagnosed in 19% (n = 9) of patients with FH-related mutations, and this diagnosis was premature for all of them.Conclusions Despite the well-known socioeconomic burden of FH worldwide, it is underdiagnosed and undertreated. Accurate diagnosis of FH, as well as detailed examination and evaluation of the FH patient, are important for initiating cascade screening of first-degree relatives. Furthermore, the implementation of such an algorithm is likely to be a cost-effective method for detecting and screening FH cases.

Publisher

Research Square Platform LLC

Reference41 articles.

1. Cuchel M, Bruckert E, Ginsberg HN, Raal FJ, Santos RD, Hegele RA et al. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Eur Heart J [Internet]. 2014 Aug 8 [cited 2023 Aug 21];35(32):2146. Available from: /pmc/articles/PMC4139706/.

2. Homozygous familial hypercholesterolemia;Nohara A;J Atheroscler Thromb,2021

3. Familial Hypercholesterolemia—Epidemiology, Diagnosis, and Screening;Singh S;Curr Atheroscler Rep,2015

4. Successful genetic screening and creating awareness of familial hypercholesterolemia and other heritable Dyslipidemias in the Netherlands;Zuurbier LC;Genes (Basel),2021

5. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement fromthe European Atherosclerosis Society Consensus Panel;Ference BA;Eur Heart J,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3